EUVIMEDEUVIMED entdecken
Open Access

Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation

Saeko Iikura, Yuki Ikeda, Shohei Nakahara, Yuki Watanabe, Yosuke Haruki, Yu Takigami, Yuko Eda, Yuichiro Iida, Takeru Nabeta, Shunsuke Ishii, Junya Ako

Circulation Reports · 10.04.2026 · 8 (4) · 580-588

DOI: 10.1253/circrep.cr-25-0283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Reports, erschienen am 10.04.2026. Verfasst von Saeko Iikura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical differences between intra-aortic balloon pumping (IABP) and a microaxial flow pump (Impella) for left ventricular (LV) unloading in patients with fulminant myocarditis (FM) supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO) remain unclear. Methods and Results: In this single-center, retrospective cohort study, we analyzed 27 consecutive patients with lymphocytic FM who received VA-ECMO support. Patients were stratified by the LV unloading device that was used: IABP (n=15); or Impella (n=12). The primary endpoint was a composite of all-cause mortality or implantation of an extracorporeal ventricular assist device (exVAD) within 30 days of VA-ECMO initiation. Temporal changes in laboratory and hemodynamic parameters during the first 7 days of support were also assessed. Baseline characteristics, including LV ejection fraction (IABP 16% vs. Impella 18%; P=0.814) and QRS duration (139 vs. 105 ms; P=0.805), were comparable between groups. Nine patients met the primary endpoint (mortality [n=7]; exVAD implantation [n=2]). Kaplan-Meier analysis revealed a significantly lower incidence of the primary endpoint in the Impella group (log-rank P=0.018). The Impella group also showed a significantly greater improvement in cardiac power output (group×time interaction, P=0.040). Hemolysis, elevated total bilirubin, and increased serum creatinine were more pronounced in the Impella group.

Conclusions

In patients with FM requiring VA-ECMO, LV unloading with Impella was associated with improved short-term clinical outcomes compared with IABP.

Schlagwörter

Stichwörter der Autor:innen

Fulminant myocarditisImpellaIntra-aortic balloon pump (IABP)Venoarterial extracorporeal membrane oxygenation (VA-ECMO)

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.

Zitieren

APA

Iikura, S., Ikeda, Y., Nakahara, S., Watanabe, Y., Haruki, Y., Takigami, Y., Eda, Y., Iida, Y., Nabeta, T., Ishii, S., & Ako, J. (2026). Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation. Circulation Reports, 8(4), 580-588. https://doi.org/10.1253/circrep.cr-25-0283

Vancouver

Iikura S, Ikeda Y, Nakahara S, Watanabe Y, Haruki Y, Takigami Y, et al. Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation. Circulation Reports. 2026;8(4):580-588. doi:10.1253/circrep.cr-25-0283

BibTeX
@article{Iikura2026,
  author = {Iikura, Saeko and Ikeda, Yuki and Nakahara, Shohei and Watanabe, Yuki and Haruki, Yosuke and Takigami, Yu and Eda, Yuko and Iida, Yuichiro and Nabeta, Takeru and Ishii, Shunsuke and Ako, Junya},
  title = {Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation},
  journal = {Circulation Reports},
  year = {2026},
  volume = {8},
  number = {4},
  pages = {580--588},
  doi = {10.1253/circrep.cr-25-0283}
}
Kostenlos starten →